Browsing Institut des Maladies Neurodégénératives (IMN) - UMR 5293 by Title
Now showing items 66-85 of 102
-
Understanding factors associated with the trajectory of subjective cognitive complaints in groups with similar objective cognitive trajectories
(Alzheimer's research & therapy. vol. 15, n° 1, pp. 205, 2023-11-22)Article de revueOpen access -
Usefulness of thalamic beta activity for closed-loop therapy in essential tremor
(Scientific Reports. vol. 13, n° 1, 2023-12)Article de revueOpen access -
Alterations in electrochemical skin conductance as a marker of autonomic dysfunction in multiple system atrophy
(Parkinsonism and Related Disorders. vol. 103, pp. 56-59, 2022-08-28)Article de revueOpen access -
An Item Response Theory analysis of the Unified Multiple System Atrophy Rating Scale
(Parkinsonism and Related Disorders. vol. 94, pp. 40-44, 2021-11-30)Article de revue -
Diagnostic value of cerebrospinal fluid alpha-synuclein seed quantification in synucleinopathies
(Brain - A Journal of Neurology, 2021-12-11)Article de revueOpen access -
GRK2‐ Targeted Knockdown as Therapy for Multiple System Atrophy
(Movement Disorders. vol. 38, n° 7, pp. 1336-1340, 2023-07)Article de revueOpen access -
A Biological Index to Screen Multi-Micronutrient Deficiencies Associated with the Risk to Develop Dementia in Older Persons from the Community
(Journal of Alzheimer's disease, 2021-11-18)Article de revue -
PLGA-Based Nanoparticles for Neuroprotective Drug Delivery in Neurodegenerative Diseases
(Pharmaceutics. vol. 13, n° 7, 2021-07-08)Article de revueOpen access -
Striatopallidal cannabinoid type-1 receptors mediate amphetamine-induced sensitization
(2023-10)Document de travail - Pré-publicationOpen access -
Assessment of Mendelian and risk factor genes in Alzheimer disease: a prospective nationwide clinical utility study and recommendations for genetic screening
(Genetics in Medicine. pp. 101082, 2024-01-24)Article de revueOpen access -
Craving dynamics and related cerebral substrates predict timing of use in alcohol, tobacco, and cannabis use disorders
(Addiction Neuroscience. vol. 9, 2023-12-15)Article de revueOpen access -
Patient-perceived progression in multiple system atrophy: natural history of quality of life
(Journal of Neurology, Neurosurgery and Psychiatry, 2024-03-07)Article de revueOpen access -
Camkiiβ in neuronal development and plasticity: An emerging candidate in brain diseases
(International Journal of Molecular Sciences. vol. 21, n° 19, pp. 1-15, 2020-10-01)Article de revueOpen access -
Structural progression of Alzheimer's disease over decades: The MRI staging scheme
(Brain Communications. vol. 4, n° 3, 2022-04-28)Article de revueOpen access -
The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations
(Movement Disorders. vol. 37, n° 12, pp. 2336-2341, 2022-09-08)Article de revueOpen access -
Lifespan neurodegeneration of the human brain in multiple sclerosis
(Human Brain Mapping. vol. 44, n° 17, pp. 5602-5611, 2023-03-14)Article de revueOpen access -
Hippocampal-amygdalo-ventricular atrophy score: Alzheimer disease detection using normative and pathological lifespan models.
(Human Brain Mapping. vol. 43, n° 10, pp. 3270-3282, 2022-07)Article de revueOpen access -
Macros to Quantify Exosome Release and Autophagy at the Neuromuscular Junction of Drosophila Melanogaster
(Frontiers in Cell and Developmental Biology. vol. 9, 2021-11-15)Article de revueOpen access -
Retinal microvasculature and incident dementia over 10 years: The Three-City-Alienor cohort
(Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring. vol. 15, n° 4, pp. e12480, 2023-10)Article de revueOpen access -
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
(Science Advances. vol. 6, n° 20, 2020-05-13)Article de revueOpen access